ReviewReviews in endocrine & metabolic disorders2026
Role of sex and gender in autoimmune thyroid diseases: mechanisms and knowledge gaps.
Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune thyroid diseases (AITDs), mainly Hashimoto's thyroiditis and Graves' disease, are the most common organ-specific autoimmune disorders and display one of the strongest sex biases in autoimmunity, with a marked female predominance. This review examines how biological sex and gender-related determinants shape AITD susceptibility, expression, and clinical heterogeneity, and their relevance to personalized care. PubMed/MEDLINE and Scopus were searched from inception to June 2026, with Web of Science used for forward citation tracking. Human studies, reviews and meta-analyses, and selected experimental studies addressing sex- and gender-related mechanisms relevant to thyroid autoimmunity were considered. Sexual dimorphism in immune function provides the biological background for the higher autoimmune susceptibility of women, who generally mount stronger innate and adaptive immune responses. Sex hormones modulate immune tolerance and inflammation, while X-chromosome dosage, incomplete or skewed X-chromosome inactivation, X-linked immune genes, and emerging Y-chromosome-related mechanisms further contribute to immune regulation. Epigenetic mechanisms may amplify sex-dependent immune responses. Pregnancy, postpartum immune rebound, reproductive history, and fetal microchimerism highlight the interaction between reproductive biology and thyroid autoimmunity. Environmental exposures, smoking, psychosocial stress, occupational patterns, and healthcare-related determinants add a gender-related dimension, while sex-specific gut microbiota differences may also contribute. However, major knowledge gaps remain. Sex-stratified analyses are often lacking, and AITD-specific evidence on epigenetic profiles, microbiota, and gender-related determinants remains limited. Integrating sex and gender into AITD research and clinical practice may improve risk stratification, diagnosis, prevention, and individualized management, supporting a precision-medicine approach to thyroid autoimmunity.
Indexed as
Identifiers
42766068What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.